Literature DB >> 7545249

A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase.

B Kim1, L A Loeb.   

Abstract

Human immunodeficiency virus (HIV) reverse transcriptase substitutes for temperature-sensitive DNA polymerase I (Pol Its) in Escherichia coli, providing a screen for anti-HIV reverse transcriptase nucleoside analogs in bacteria. Since phosphorylation of nucleosides in E. coli is limited to thymidine and its derivatives, we coexpressed herpes simplex virus thymidine kinase, an enzyme that phosphorylates a wide variety of nucleoside analogs, together with HIV reverse transcriptase. Coexpression of herpes simplex virus thymidine kinase and HIV reverse transcriptase rendered Pol Its cells sensitive to dideoxycytidine. Studies with different nucleoside analogs indicate that this bacterial screening system is able to select and identify nucleoside analogs that specifically target HIV reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545249      PMCID: PMC189560     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  DEOXYTHYMIDINE KINASE OF ESCHERICHIA COLI. II. KINETICS AND FEEDBACK CONTROL.

Authors:  R OKAZAKI; A KORNBERG
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase.

Authors:  V R Prasad; I Lowy; T de los Santos; L Chiang; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Selection of new biologically active molecules from random nucleotide sequences.

Authors:  D K Dube; M E Black; K M Munir; L A Loeb
Journal:  Gene       Date:  1993-12-27       Impact factor: 3.688

4.  Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro.

Authors:  M E Black; L A Loeb
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

5.  A possible role for cysteine residues in the fidelity of DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

Authors:  M Bakhanashvili; A Hizi
Journal:  FEBS Lett       Date:  1992-06-15       Impact factor: 4.124

6.  Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.

Authors:  Z Gu; Q Gao; X Li; M A Parniak; M A Wainberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Thymidine kinase mutants obtained by random sequence selection.

Authors:  K M Munir; D C French; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior.

Authors:  Y C Cheng
Journal:  Biochim Biophys Acta       Date:  1976-12-08

9.  Human immunodeficiency virus reverse transcriptase substitutes for DNA polymerase I in Escherichia coli.

Authors:  B Kim; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Detection and characterization of mammalian DNA polymerase beta mutants by functional complementation in Escherichia coli.

Authors:  J B Sweasy; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  2 in total

1.  Random mutagenesis of Thermus aquaticus DNA polymerase I: concordance of immutable sites in vivo with the crystal structure.

Authors:  M Suzuki; D Baskin; L Hood; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase.

Authors:  D V Nissley; P L Boyer; D J Garfinkel; S H Hughes; J N Strathern
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.